Phytochemicals As a Potential Inhibitor of COVID-19: An In-Silico Perspective
- 1 July 2022
- journal article
- research article
- Published by Pleiades Publishing Ltd in Russian Journal of Physical Chemistry A
- Vol. 96 (7) , 1589-1597
Abstract
The current research has centered on the use of pharmacological and binding affinity methods to test the 36 compounds as bioactive constituents’ inhibitors for COVID-19. Six compounds out of 36 phytoconstituents (rutin, quercetin, catechin gallate, rhamnetin, campesterol and stigmasterol) have demonstrated outstanding molecular docking and drug-like properties as HIV inhibitors Lopinavir and Indinavir. Interestingly, the lowest binding energies (LBE) and the inhibition constant (Ki) have showed that these compounds are able to bind to the P-glycoprotein substrate of 3CLpro and Nsp15. Interestingly, rutin has been found to be an excellent potential inhibitor for COVID-19 proteins because it has the best LBE score and Ki value than those of other compounds, and of its ability to form strong H-bonds with COVID-19 proteins. The compounds that come next to the rutin compound are stigmasterol and campesterol. As a result, these compounds are considered possible novel inhibitors of COVID-19. In order to validate the computational results, more in vitro and in vivo investigations are required to support the findings of this research.Keywords
This publication has 27 references indexed in Scilit:
- Potential interventions for novel coronavirus in China: A systematic reviewJournal of Medical Virology, 2020
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)Nature Reviews Drug Discovery, 2020
- Principle components analysis for seizures prediction using wavelet transformInternational Journal of ADVANCED AND APPLIED SCIENCES, 2019
- Extended Hückel Calculations on Solids Using the Avogadro Molecular Editor and VisualizerJournal of Chemical Education, 2017
- Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications.2016
- Crystallization and preliminary X-ray crystallographic analysis of a nonstructural protein 15 mutant fromHuman coronavirus 229EActa Crystallographica Section F Structural Biology Communications, 2015
- Ivermectin: panacea for resource-poor communities?Trends in Parasitology, 2014
- Phytochemicals to Prevent Inflammation and AllergyRecent Patents on Inflammation & Allergy Drug Discovery, 2012
- Toxicity of bloodmeals from ivermectin-treated cattle toAnopheles gambiaes.l.Pathogens and Global Health, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009